Literature DB >> 20823073

Should the size threshold for elective abdominal aortic aneurysm repair be lowered in the endovascular era? Yes.

Kosmas I Paraskevas1, Dimitri P Mikhailidis, Vassilios Andrikopoulos, Nikolaos Bessias, Sir Peter R F Bell.   

Abstract

According to current international guidelines, patients with infrarenal or juxtarenal abdominal aortic aneurysms (AAAs) measuring > or = 5.5 cm should undergo repair to reduce the risk of rupture. The 5.5-cm-diameter threshold is the size when the AAA rupture rate balances the mortality rates of elective open surgical AAA repair (3%). Endovascular AAA repair (EVAR) is associated with lower perioperative mortality and complication rates compared with open surgical repair. This debate addresses the issue whether the current size threshold for elective AAA repair needs to be lowered in the endovascular era. This paper supports the position that the size threshold for AAA repair should be lowered in the endovascular era.

Entities:  

Mesh:

Year:  2010        PMID: 20823073     DOI: 10.1177/0003319710375084

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  Late mortality in females after endovascular aneurysm repair.

Authors:  Joshua E Preiss; Shipra Arya; Yazan Duwayri; Susan M Shafii; Ravi K Veeraswamy; Ravi R Rajani; Thomas F Dodson; Luke P Brewster
Journal:  J Surg Res       Date:  2015-04-04       Impact factor: 2.192

2.  Machine learning approaches to surrogate multifidelity Growth and Remodeling models for efficient abdominal aortic aneurysmal applications.

Authors:  Zhenxiang Jiang; Jongeun Choi; Seungik Baek
Journal:  Comput Biol Med       Date:  2021-04-15       Impact factor: 6.698

3.  Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening.

Authors:  Matthew J Glover; Edmund Jones; Katya L Masconi; Michael J Sweeting; Simon G Thompson
Journal:  Med Decis Making       Date:  2018-04-02       Impact factor: 2.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.